EGFR and adenocarcinoma: Our identification of a low-risk consensus group across 10 different GEP signatures further show that low-risk adenocarcinomas typically have higher expression of surfactant proteins and Napsin A, and are associated with clinicopathological characteristics such as lower tumor stage, never-smoking, female gender and oncogene activation (including EGFR mutations) (Figure 5).